Astec LifeSciences (ASTEC)₹527.20−7.07%Pesticides & Agrochemicals
Astec LifeSciences is compared with the 10 closest in size in Pesticides & Agrochemicals (34 companies in the industry). It has a ROCE of −5.0% against a peer median of 14.0%, and latest-quarter sales growth of −2.7% against a peer median of 2.4%. By market cap it is #8 of 11 in this set.
As of · Peer set: 10 closest in size in Pesticides & Agrochemicals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sharda Cropchem | 6,228 | 9.7 | 30.1 | 23.2 | 0.00 | 2.2 | 5,259 | 679 | 13.3 | 24.2 | vs ASTEC |
| Dhanuka Agritech | 4,092 | 14.4 | 27.9 | 20.5 | 0.02 | 0.2 | 2,015 | 287 | 10.0 | 16.0 | vs ASTEC |
| Rallis India | 3,656 | 17.1 | 14.0 | 10.2 | 0.03 | 1.6 | 2,896 | 184 | 6.8 | 31.6 | vs ASTEC |
| NACL Industries | 2,821 | 227.5 | 8.0 | 2.4 | 0.46 | 0.0 | 1,579 | 5 | −14.4 | 61.6 | vs ASTEC |
| GSP Crop Science | 2,009 | 18.1 | 19.1 | 16.5 | 0.34 | 0.2 | 1,521 | 95 | 2.4 | 13.1 | vs ASTEC |
| Meghmani Organics | 1,371 | 21.6 | 7.0 | 1.9 | 0.47 | 0.0 | 2,174 | 29 | −11.6 | 269.8 | vs ASTEC |
| India Pesticides | 1,343 | 12.4 | 17.0 | 12.6 | 0.11 | 0.6 | 1,060 | 120 | −8.4 | −34.2 | vs ASTEC |
| Astec LifeSciences | 1,176 | — | −5.0 | −25.3 | 1.16 | 0.0 | 447 | −81 | −2.7 | — | — |
| Advance Agrolife | 783 | 14.1 | 18.9 | 17.2 | 0.32 | 0.0 | 635 | 35 | 95.3 | 155.5 | vs ASTEC |
| Best Agrolife | 528 | 10.9 | 5.0 | 1.1 | 0.58 | 0.7 | 1,257 | 9 | −21.2 | 46.1 | vs ASTEC |
| Shivalik Rasayan | 488 | 35.9 | 5.0 | 2.1 | 0.19 | 0.2 | 368 | 18 | 7.8 | 59.8 | vs ASTEC |
| Peer median | 1,371 | 15.8 | 14.0 | 10.2 | 0.32 | 0.2 | 1,521 | 35 | 2.4 | 38.8 |
Listed companies closest to Astec LifeSciences in Pesticides & Agrochemicals include Sharda Cropchem, Dhanuka Agritech, Rallis India, NACL Industries, GSP Crop Science, Meghmani Organics, India Pesticides, Advance Agrolife.
Sharda Cropchem, with a market cap of ₹6,228 Cr.
Astec LifeSciences' return on capital employed is −5.0%, below the peer median of 14.0%.